Hl60 cell line and the blood and immune line panels

Suspension lines are easier to grow than adherent ones and harder to use well, because most of them are bought for a behaviour rather than for a phenotype: a line that differentiates on treatment, a line whose survival depends on one signal, a line that presents antigen. What the line does under a stimulus is the product, and that behaviour drifts with passage more visibly than a growth rate does.

the authentication expected of key biological resources
NIH rigor
the containment level most routine human cell work is handled at
BSL-2
the guidance on deriving and characterising a cell substrate
Q5D

The figures in this panel are regulation and standard identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a price index it has not measured.

What to settle before a suspension line is ordered

  1. Establish what the line is a model of. A line that differentiates toward a mature phenotype on treatment models a process; a line that dies without a cytokine models a dependence; a line derived from a tumour models that tumour. These are different uses and a line is rarely good at more than one of them.
  2. Fix the differentiation protocol before the experiments. Where the readout follows a differentiation step, the agent, the concentration and the duration are part of the model and change the result substantially. Fix them, record them, and treat a change in protocol as a change in the model rather than a detail.
  3. Watch the passage window. Differentiation capacity and cytokine dependence both fade with continued passage, often before anything looks wrong. Work within a stated passage window from a banked stock and return to the bank rather than carrying a culture indefinitely.
  4. Keep the dependence in a dependence assay. A line that survives only with one signal is a clean readout for whether that signal is active, and it stops being clean the moment a subpopulation adapts. Include the withdrawal control in every run, not only when the assay was set up.
  5. Know when the answer is a primary cell. Some populations have no representative line at all, and work on them uses sorted primary cells with donor variability, limited numbers and a lifespan. Recognising that early avoids a search for a line that does not exist.

Differentiation models, and what THP-1 cells are not

A cultured line pushed toward a mature phenotype resembles the mature cell in some respects and not in others, and which respects depends on the agent used. Two laboratories differentiating the same line by different protocols are working with two different models.

Where the conclusion concerns the mature cell itself, primary cells are the stronger evidence and the line is the tractable screen. Using the line to generate hypotheses and the primary cells to test the important ones is the arrangement that usually survives review.

Mouse lines, human lines and what transfers

Mouse immune lines are used because they can be transferred into an immunocompetent animal of the matching strain, which no human line permits. The price is that the immunology is mouse immunology, and several receptor families differ enough between species that a result does not transfer.

State which species the model is and why it was chosen. A mouse macrophage line is an excellent tool for an innate signalling question and a poor stand-in for a human one where the receptor repertoire differs.

Lines as targets in killing assays

Suspension lines are widely used as targets for immune effector assays because they are uniform, easy to label and easy to count. The choice of target then determines what the assay measures, since surface antigen density and sensitivity to the killing mechanism vary between lines.

Report the target line, its antigen level and the effector to target ratio, and include a line that does not express the antigen. Without that negative the assay measures killing rather than specific killing.

Model antigens and what they standardise

A great deal of mouse immunology is built on a small number of well-characterised epitopes, because the matching receptor-transgenic mice, tetramers and peptide reagents all exist. That standardisation is what lets results be compared between laboratories.

It also means the system is a model of antigen recognition rather than of a real pathogen or tumour antigen, and affinity and immunogenicity are frequently far higher than anything physiological. Results transfer as mechanism rather than as magnitude.

A mouse macrophage cell line, usually raw 264.7

A request for a mouse macrophage cell line is usually answered by raw 264.7, a transformed line that is adherent, easy to grow and responsive to bacterial ligands, which is why it stands in for a primary macrophage in most screens. It is not a primary cell: the receptor repertoire is narrower, so a result that matters is repeated in bone marrow derived cells.

nalm6 cells and the leukaemia models beside them

nalm6 cells are a B cell precursor leukaemia line used as a target in cytotoxicity and engineered cell work, and they are chosen for a stable surface antigen and easy transduction rather than for fidelity to a patient. Authentication is the whole risk with these lines, since sublines circulate with different antigen levels.

k562 cell lines and the variants in circulation

k562 cell lines exist as many sublines after decades of passage, and they differ in growth rate, in surface antigen level and in their sensitivity as a natural killer target, which is why a published result names the source. Short tandem repeat profiling identifies the line but not the subline, so the supplier and passage are part of the method.

Common questions

Why do my differentiation results drift?
Usually passage. Differentiation capacity fades before anything looks wrong, so work within a stated passage window from a banked stock and return to the bank rather than carrying a culture indefinitely.
Is a THP1 cells monocytic line a substitute for primary macrophages?
It is a tractable model of the process, not the mature cell. Use it to generate and screen hypotheses and test the important ones in primary cells, and state which protocol was used to differentiate it.
What does a factor-dependent line measure?
Whether a signal is active, because the cells die without it. Include the withdrawal control in every run, since subpopulations adapt and a line that has become independent reports nothing.
Why are so many mouse immune experiments built on a few epitopes?
Because the matching receptor-transgenic mice, tetramers and peptide reagents exist, which makes results comparable between laboratories. The trade is that affinity and immunogenicity are often far above anything physiological, so results transfer as mechanism rather than magnitude.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/haematological-cell-lines/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices